Driving Global Innovation in Health
GHIS leads global innovation in the identification, prevention and surveillance of infectious diseases.
GHIS leads global innovation in the identification, prevention and surveillance of infectious diseases.
Born from the experience of Famba, our telemedicine platform for travelers, we have enhanced it with solutions such as rapid diagnostic tests (RDT), developing products that generate reliable and valuable health data. We apply artificial intelligence and natural language processing to analyze these data alongside mobility and climate information, creating predictive algorithms that enable institutions, companies, and providers to anticipate risks and make strategic decisions. Our approach turns information into actionable knowledge, strengthening prevention, optimizing public health policies, and positioning GHIS as a trusted and strategic partner in global health innovation.
We are developing data-generating solutions, including rapid diagnostic tests (RDTs), combined with artificial intelligence and natural language processing to anticipate potential global health risks.
We aim to detect outbreaks before they escalate into epidemics using predictive algorithms.
We transform collected data into actionable insights, enabling institutions and companies to optimize strategic decisions and improve preparedness.
Preventive medicine project created to provide healthcare support at the Rio de Janeiro 2016 Olympic Games.
Telemedicine platform for travelers that collects health data and offers specialized medical guidance.
Symptom tracking, demographic data, and advanced analytics to enhance prevention.
Traveler alerts and early outbreak detection. Pilot projects in several European Travel Clinics.
We consolidated our expertise in prevention and global surveillance, integrating data and AI to deliver innovative solutions to institutions and companies.
